tetraethylammonium has been researched along with Cardiac Hypertrophy in 2 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Walsh, KB | 1 |
Sweet, JK | 1 |
Parks, GE | 1 |
Long, KJ | 1 |
Cameron, JS | 1 |
Kimura, S | 1 |
Jackson-Burns, DA | 1 |
Smith, DB | 1 |
Bassett, AL | 1 |
2 other studies available for tetraethylammonium and Cardiac Hypertrophy
Article | Year |
---|---|
Modulation of outward potassium currents in aligned cultures of neonatal rat ventricular myocytes during phorbol ester-induced hypertrophy.
Topics: Animals; Cardiomegaly; Cells, Cultured; Delayed Rectifier Potassium Channels; Electric Conductivity; | 2001 |
ATP-sensitive K+ channels are altered in hypertrophied ventricular myocytes.
Topics: 4-Aminopyridine; Adenosine Triphosphate; Aminopyridines; Animals; Calcium; Cardiomegaly; Cats; Dose- | 1988 |